Long Distance From Microvessel to Cancer Cell Predicts Poor Prognosis in Non-Small Cell Lung Cancer Patients

Long Distance From Microvessel to Cancer Cell Predicts Poor Prognosis in Non-Small Cell Lung Cancer Patients

BackgroundBlood supply, which is crucial for nutrition and drug delivery, was determined by microvessel density as well as the diffusion distance between vessels and cancer cells. Therefore, we evaluated the distance from microvessels to cancer cells (Dmvcc) and its role in the prognosis of non-smal...

Full description

Bibliographic Details
Main Authors:	Haiying Ding, Jiao Sun, Yu Song, Wenxiu Xin, Junfeng Zhu, Like Zhong, Yinbo Chen, Yiwen Zhang, Yinghui Tong, Luo Fang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-06-01
Series:	Frontiers in Oncology
Subjects:	non-small cell lung cancer prognosis marker distance from microvessel to cancer cell progression free survival overall survival
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.632352/full

Similar Items

Low Expression of Keratin17 is Related to Poor Prognosis in Bladder Cancer
by: Wu J, et al.
Published: (2021-01-01)

A Low Albumin-to-Globulin Ratio Predicts a Poor Prognosis in Patients With Metastatic Non-small-cell Lung Cancer
by: Ping Lu, et al.
Published: (2021-03-01)

Prognostic value of microvessel density in cervical cancer
by: Xiaoli Hu, et al.
Published: (2018-10-01)

Progression-free survival, post-progression survival, and tumor response as surrogate markers for overall survival in patients with extensive small cell lung cancer
by: Hisao Imai, et al.
Published: (2015-01-01)

Construction of a Novel Multigene Panel Potently Predicting Poor Prognosis in Patients with Clear Cell Renal Cell Carcinoma
by: Xiaozeng Lin, et al.
Published: (2020-11-01)

Outcomes of Patients with Pulmonary Large Cell Neuroendocrine Carcinoma in I–IV Stage
by: Anna Lowczak, et al.
Published: (2021-01-01)

Efficacy and safety of microwave ablation in the treatment of patients with oligometastatic non-small-cell lung cancer: a retrospective study
by: Zhigang Wei, et al.
Published: (2019-01-01)

Clinical impact of post-progression survival on overall survival in patients with limited-stage disease small cell lung cancer after first-line chemoradiotherapy
by: Kasahara Norimitsu, et al.
Published: (2015-12-01)

Rechallenge with First-Line Platinum Chemotherapy for Sensitive-Relapsed Small-Cell Lung Cancer
by: Toshihiro Shiozawa, et al.
Published: (2018-09-01)

From clinical trials to the front line: Vinflunine for Treatment of UrothelialCell Carcinoma at the National Cancer Institute of Naples
by: GAETANO eFACCHINI, et al.
Published: (2016-05-01)

The use of targeted therapies and selection of the optimal treatment sequence in heterogeneous population of patients with metastatic kidney cancer. Results of retrospective study
by: P. S. Borisov, et al.
Published: (2016-09-01)

Absolute Neutrophil Count in the Peripheral Blood Predicts Prognosis in Lung Cancer Patients Treated with Anlotinib
by: Chen R, et al.
Published: (2021-05-01)

Baseline Lymphopenia: A Predictor Of Poor Outcomes In HER2 positive Metastatic Breast Cancer Treated With Trastuzumab
by: Che YQ, et al.
Published: (2019-10-01)

High expression of metabolic enzyme PFKFB4 is associated with poor prognosis of operable breast cancer
by: Ling Yao, et al.
Published: (2019-06-01)

Which Should Be Used First for ALK-Positive Non-Small-Cell Lung Cancer: Chemotherapy or Targeted Therapy? A Meta-Analysis of Five Randomized Trials
by: Yen-Chien Lee, et al.
Published: (2019-01-01)

Optimal duration of a first-line palliative chemotherapy in disseminated colorectal cancer – a review of the literature from a developing country perspective
by: Wojciech Rogowski, et al.
Published: (2016-08-01)

Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients
by: Hanna Huebner, et al.
Published: (2018-02-01)

Low STYK1 expression indicates poor prognosis in gastric cancer
by: Fang J, et al.
Published: (2018-12-01)

Tumor-infiltrating γδT cells predict prognosis and adjuvant chemotherapeutic benefit in patients with gastric cancer
by: Jieti Wang, et al.
Published: (2017-11-01)

Anlotinib Combined with Cranial Radiotherapy for Non-Small Cell Lung Cancer Patients with Brain Metastasis: A Retrospectively, Control Study
by: He Z, et al.
Published: (2021-08-01)

Tumor stroma-infiltrating mast cells predict prognosis and adjuvant chemotherapeutic benefits in patients with muscle invasive bladder cancer
by: Zheng Liu, et al.
Published: (2018-09-01)

Estrogen receptor β is associated with expression of cancer associated genes and survival in ovarian cancer
by: Susanne Schüler-Toprak, et al.
Published: (2018-10-01)

Computed Tomography Based Radiomics as a Predictor of Survival in Ovarian Cancer Patients: A Systematic Review
by: Stefania Rizzo, et al.
Published: (2021-02-01)

Subtype-Based Prognostic Analysis of Cell-in-Cell Structures in Early Breast Cancer
by: Xin Zhang, et al.
Published: (2019-09-01)

Cisplatin-based chemotherapy with or without bevacizumab for Chinese postmenopausal women with advanced cervical cancer: a retrospective observational study
by: Xiaoli He, et al.
Published: (2020-05-01)

Efficacy and safety of crizotinib in patients with anaplastic lymphoma kinase-positive advanced-stage non-small-cell lung cancer
by: Mohieldin A, et al.
Published: (2018-11-01)

Improved Prognostic Stratification Using Circulating Tumor Cell Clusters in Patients with Metastatic Castration-Resistant Prostate Cancer
by: Chun Wang, et al.
Published: (2021-01-01)

Impact of diabetes mellitus on epithelial ovarian cancer survival
by: Setareh Akhavan, et al.
Published: (2018-12-01)

Capecitabine plus bevacizumab versus capecitabine in maintenance treatment for untreated characterised KRAS exon 2 wild-type metastatic colorectal cancer: a retrospective analysis in Chinese postmenopausal women
by: Jinsong Su, et al.
Published: (2019-01-01)

Prognostic impact of tumor mutation burden and the mutation in KIAA1211 in small cell lung cancer
by: Mengting Zhou, et al.
Published: (2019-11-01)

A Case Series of Survival Outcomes in Patients with Advanced-stage IIIb/IV Non-small-cell Lung Cancer Treated with HangAm-Plus
by: Bang Sun-Hwi, et al.
Published: (2012-06-01)

Antiangiogenic drugs used with chemotherapy for patients with recurrent ovarian cancer: a meta-analysis
by: Yi SY, et al.
Published: (2017-02-01)

Treatment Outcomes of Metastatic Colorectal Cancer Patients Treated with Regorafenib as Third-Line Setting-A Multicenter Study
by: Süleyman Şahin, et al.
Published: (2019-03-01)

Impact of somatic mutations on prognosis in resected non‐small‐cell lung cancer: The Japan Molecular Epidemiology for lung cancer study
by: Akihiro Tamiya, et al.
Published: (2020-04-01)

Incidence and prognostic factors in patents (pts) with mutant BRAF (mBRAF) metastatic colorectal cancer (mCRC) in Russia
by: M. Yu. Fedyanin, et al.
Published: (2021-06-01)

Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients
by: Xiaobo Bo, et al.
Published: (2018-03-01)

Combining Lactate Dehydrogenase and Fibrinogen: Potential Factors to Predict Therapeutic Efficacy and Prognosis of Patients with Small-Cell Lung Cancer
by: Huang W, et al.
Published: (2021-05-01)

Rankl expression predicts poor prognosis in gastric cancer patients: results from a retrospective and single-center analysis
by: X. Zhang, et al.
Published: (2018-01-01)

Impact of adjuvant chemotherapy on outcomes in appendiceal cancer
by: Bhaskar C. Kolla, et al.
Published: (2020-05-01)

No relationship between the distribution of mast cells and the survival of stage IIIB colon cancer patients
by: Jing-Zeng, et al.
Published: (2011-06-01)